Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Buzoianu, A.D. et al. (2023). RETRACTED CHAPTER: Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson’s Disease. In: Sharma, H.S., Sharma, A. (eds) Progress in Nanomedicine in Neurologic Diseases. Advances in Neurobiology, vol 32. Springer, Cham. https://doi.org/10.1007/978-3-031-32997-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-32997-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-32996-8
Online ISBN: 978-3-031-32997-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)